Pronóstico del mercado genómico de América del Norte hasta 2027: impacto de COVID-19 y análisis regional por tecnología (secuenciación, microarrays, reacción en cadena de la polimerasa (PCR), extracción y purificación de ácidos nucleicos, y otros), productos y servicios (instrumentos/sistemas, consumibles y Servicios), Aplicación (Diagnóstico, Descubrimiento y Desarrollo de Fármacos, Medicina de Precisión/Personalizada, Investigación Agrícola y Animal, y otros), Usuario Final (Centros de Investigación, Hospitales y Clínicas, Empresas Farmacéuticas y de Biotecnología, y otros), y País

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 234    |    Report Code: TIPRE00004301    |    Category: Life Sciences

North America Genomics Market

Se espera que el mercado de genómica de América del Norte alcance los 20.348,43 millones de dólares en 2027 desde los 7.669,34 millones de dólares de 2019. Se estima que el mercado crecerá con una tasa compuesta anual del 13,3% entre 2020 y 2027.< /strong>

La genómica se define como el estudio de un gen y su funcionamiento. La genómica se utiliza para examinar los mecanismos moleculares y la interacción de factores genéticos y ambientales en las enfermedades. Los principales factores que se atribuyen al crecimiento del mercado de la genómica son el creciente apoyo gubernamental y el mayor número de estudios de genómica, la disminución del costo de secuenciación y el aumento de las aplicaciones de genómica. El alcance del mercado de genómica incluye tecnología, productos y servicios, aplicaciones, finales -usuario y región.

Ingresos del mercado genómico de EE. UU. y pronósticos hasta 2027 (US$ MN)

< /span>

SEGMENTACIÓN DEL MERCADO DE GENÓMICA DE AMÉRICA DEL NORTE

Por tecnología

  • Secuenciación
  • Microarrays
  • < span>Reacción en cadena de la polimerasa
  • Extracción y purificación de ácidos nucleicos
  • Otros

Por producto y servicios

  • Instrumentos/Sistemas
  • Consumibles
  • Servicios

Por aplicación

  • Diagnóstico
  • Descubrimiento y desarrollo de fármacos
  • Medicina de precisión/personalizada
  • Agricultura y agricultura Investigación con animales
  • Otros

Por usuario final

    < li>Centros de investigación
  • Hospitales y centros de investigación. Clínicas
  • Biotecnología & Empresas farmacéuticas
  • Otros

Por país

  • América del Norte

    • EE.UU.
    • < li>Canadá
    • México

 

Perfiles de empresas

  • Illumina, Inc.
  • < li class=\"MsoNormalCxSpMiddle\">Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • BIO-RAD LABORATORIES INC.
  • Compañía General Electric
  • THERMO FISHER SCIENTIFIC INC.
  • Agilent Technologies, Inc .
  • Eurofins Scientific
  • QIAGEN
  • BGI


North America Genomics Strategic Insights

Strategic insights for North America Genomics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-genomics-market-strategic-framework.webp
Get more information on this report

North America Genomics Report Scope

Report Attribute Details
Market size in 2019 US$ 7,669.34 Million
Market Size by 2027 US$ 20,348.43 Million
Global CAGR (2020 - 2027) 13.3%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Tecnología
  • Secuenciación
  • Microarrays
  • Reacción en cadena de la polimerasa
  • Extracción y purificación de ácidos nucleicos
By Producto y servicio
  • instrumentos/sistemas
  • consumibles
  • servicios
By Aplicación
  • diagnóstico
  • descubrimiento y desarrollo de fármacos
  • medicina de precisión/personalizada
  • agricultura e investigación animal
By Usuario final
  • centros de investigación
  • hospitales y clínicas
  • empresas farmacéuticas y biotecnológicas
Regions and Countries Covered América del Norte
  • EE. UU.
  • Canadá
  • México
Market leaders and key company profiles
  • Illumina, Inc.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • BIO-RAD LABORATORIES INC.
  • General Electric Company
  • THERMO FISHER SCIENTIFIC INC.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • QIAGEN
  • BGI
  • Get more information on this report

    North America Genomics Regional Insights

    The regional scope of North America Genomics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-genomics-market-geography.webp
    Get more information on this report

    The List of Companies - North America Genomics Market

    1. Illumina, Inc.
    2. Danaher
    3. F. HOFFMANN-LA ROCHE LTD.
    4. BIO-RAD LABORATORIES INC.
    5. General Electric Company
    6. THERMO FISHER SCIENTIFIC INC.
    7. Agilent Technologies, Inc.
    8. Eurofins Scientific
    9. QIAGEN
    10. BGI

     

     

    Frequently Asked Questions
    How big is the North America Genomics Market?

    The North America Genomics Market is valued at US$ 7,669.34 Million in 2019, it is projected to reach US$ 20,348.43 Million by 2027.

    What is the CAGR for North America Genomics Market by (2020 - 2027)?

    As per our report North America Genomics Market, the market size is valued at US$ 7,669.34 Million in 2019, projecting it to reach US$ 20,348.43 Million by 2027. This translates to a CAGR of approximately 13.3% during the forecast period.

    What segments are covered in this report?

    The North America Genomics Market report typically cover these key segments-

  • Tecnología (Secuenciación, Microarrays, Reacción en cadena de la polimerasa, Extracción y purificación de ácidos nucleicos)
  • Producto y servicio (instrumentos/sistemas, consumibles, servicios)
  • Aplicación (diagnóstico, descubrimiento y desarrollo de fármacos, medicina de precisión/personalizada, agricultura e investigación animal)
  • What is the historic period, base year, and forecast period taken for North America Genomics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Genomics Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in North America Genomics Market?

    The North America Genomics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Illumina, Inc.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • BIO-RAD LABORATORIES INC.
  • General Electric Company
  • THERMO FISHER SCIENTIFIC INC.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • QIAGEN
  • BGI
  • Who should buy this report?

    The North America Genomics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Genomics Market value chain can benefit from the information contained in a comprehensive market report.